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Abstract 
Intracortical microprobes allow the precise monitoring of electrical and chemical signaling and are 
widely used in neuroscience. Microelectromechanical system (MEMS) technologies have greatly 
enhanced the integration of multifunctional probes by facilitating the combination of multiple 
recording electrodes and drug delivery channels in a single probe. Depending on the neuroscientific 
application, various assembly strategies are required in addition to the microprobe fabrication itself. 
This paper summarizes recent advances in the fabrication and assembly of micromachined silicon 
probes for drug delivery achieved within the EU-funded research project NeuroProbes. The described 
fabrication process combines a two-wafer silicon bonding process with deep reactive ion etching, 
wafer grinding, and thin film patterning and offers a maximum in design flexibility. By applying this 
process, three general microprobe comb designs featuring up to four 8-mm-long shafts, cross sections 
from 150×200 to 250×250 µm², and different electrode and fluidic channel configurations are realized. 
Furthermore, we discuss the development and application of different probe assemblies for acute, 
semi-chronic, and chronic applications, including comb and array assemblies, floating microprobe 
arrays, as well as the complete drug delivery system NeuroMedicator for small animal research. 
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Introduction 
One of the fundamental goals of neuroscience is to understand how the central nervous system 
integrates information and controls behavior by electrical and chemical signaling. Microprobe 
technology is at the forefront of this research as it enables such activity to be measured on timescales 
consistent with cognitive processing in the brain, including decision-making and working memory. In 
this regard, the combination of electrophysiological recording with intracortical drug delivery would 
provide a powerful tool to investigate neural coding of behavior and cognition. 
Typically, pharmacological intervention in neuroscience research employs either microiontophoresis 
or pressure-driven liquid infusion systems to deliver drugs in the brain [1,2]. Today, pressure-driven 
systems based on stainless steel or glass capillaries are more commonly used as they are independent 
of the charge states of the drug molecules. In addition, the rapid development of 
microelectromechanical systems (MEMS) and the associated silicon-based fabrication processes have 
opened new technological perspectives with respect to functional microprobe integration. Following 
the pioneering work of Wise et al. [3], a wide variety of micromachined probes has been developed 
[4]. Depending on the number and geometrical arrangement of the probe shafts, one-dimensional (1D) 
single-shaft probes, two-dimensional (2D) probe combs with multiple shafts, and fully three-
dimensional (3D) microprobe arrays can be distinguished.  
Given the disc-like shape of silicon wafers, most often in-plane fabrication sequences are applied to 
realize microprobes with lengths of several millimeters, i.e. probe combs are fabricated in the wafer 
plane. Considering neural microprobes which combine electrodes and microfluidic channels for 
electrical recording and drug delivery, respectively, various materials and technological approaches 
have been pursued. This includes microprobes based on silicon (Si) [5-10], silicon-on-insulator (SOI) 
[11,12], and polymers such as parylene (Py) [13-15], polyimide (PI) [16,17], and SU-8 [18]. In 
addition to these main approaches, less common fabrication technologies have also been reported, e.g. 
a hybrid assembly affixing a silicon microelectrode array to a fused silica capillary [19]. 
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Integration of microfluidic channels into the probe body is certainly the most challenging aspect of 
this kind of probes. Thereby, surface micromachined [13,14], buried [5-7,11,12], and bonded [8-
10,15-18] channels can be generally distinguished. Surface micromachined channels are fabricated by 
deposition and subsequent etching of thin films and require sacrificial layers during fabrication. 
Typically, this technological approach results in rather low channel profiles not higher than ten 
micrometers with widths of a few ten micrometers. Buried channels are predominantly implemented in 
Si or SOI substrates. The approach requires first to etch a cavity into the substrate by dry or wet 
etching methods which is subsequently sealed by the deposition of additional layers such as oxides or 
polymers. Bonded channels are fabricated by first implementing an open channel structure in or on a 
substrate. This is followed by bonding of a second structure which seals the open channel, i.e. a 
structured or unstructured cover. Comparing the three different approaches with respect to the 
microfluidic design flexibility, the bonding approach is least restricted by the applied fabrication 
technologies and offers maximum flexibility. 
The electrodes on the probes are typically fabricated by patterning of thin films and are made of 
materials such as platinum (Pt) [7,11,16-18] including Pt-grey [8] and Pt-black [14], gold (Au) 
[6,7,10,12,13,15], or iridium (Ir) [5]. 
Depending on the specific neuroscientific application, different microprobe designs are required to 
reach the relevant areas of the brain. Thereby, the drug delivery functionality has been mostly limited 
to 1D or 2D probes. So far, full 3D arrays with individual micromachined drug delivery shafts have 
only been addressed by two approaches [6,20]. In addition, the micromachined probes have to be 
integrated into system assemblies offering distinct electrical and fluidic interfaces for the connection 
of macro-scale electronic and fluidic equipment. This is mandatory in order to be able to operate the 
microprobes during experiments. In this respect, acute and chronic assemblies have to be 
distinguished. Whereas acute assemblies are designed for short-term application, typically on a 
timescale of hours, and are easily fixed to laboratory equipment, chronic assemblies are implanted 
over longer timescales, typically weeks, and must allow animals the ability to behave in an 
unconstrained and natural manner. 
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Electrical interfacing is commonly effected by taking advantage of the broad range of integrated 
circuit (IC) packaging technologies. For this purpose, nearly all microprobes feature contact pads 
predominantly used for wire bonding to printed circuit boards (PCBs) or flexible cables which are in 
both cases terminated with electrical connectors. Alternatively, connectors can be soldered to the pads 
[17], reversible contact mechanisms used [18,21], or the pads directly inserted into zero insertion force 
(ZIF) connectors in case of flexible substrates [15,16]. Consequently, electronic equipment can be 
easily connected and disconnected to the probes. This is especially interesting for all chronic 
applications. On the other hand, fluidic interfacing requiring the transmission of matter is more 
complicated. A pluggable microfluidic connection to implanted probes is challenging, possibly 
introducing contaminations or bubbles into the system. Therefore, drug delivery is currently mostly 
limited to acute experiments. For this purpose, different kinds of tubing [5,7,11-16] or capillaries [17] 
are typically irreversibly attached to the probes and connected to macroscopic laboratory pumps. In 
addition, interfacing with O-rings was addressed [18,21]. So far, few approaches have targeted the 
integration of active micropumping components into multifunctional microprobes [10,22].  
Currently, neuroscientific experiments are predominantly performed with small animals such as rats 
and mice. In order to enable liquid infusions, different implantable general purpose drug delivery 
systems such as the iPRECIO
®
 micro infusion pump (Primetech Corporation, Tokyo, Japan) and the 
ithetis™ drug delivery device (Antlia SA, Lausanne, Switzerland) are commercially available or are 
under development [23]. However, these devices are not specifically adapted to micromachined probes 
and designed for relatively large liquid volumes of up to 1 mL. In general, few miniaturized systems 
for small animal research specifically addressing intracortical drug delivery by microprobes have been 
reported so far [24-28]. Whereas early approaches applied either chemitrodes [24] or stainless steel 
capillaries [25,26] as microprobes, the most recent approaches exploit the extended possibilities of 
micromachined probes [27,28]. 
The work described in this paper reviews the drug delivery approaches pursued within the EU-funded 
NeuroProbes project [29,30] targeting the development of multifunctional 1D, 2D, and 3D neural 
probe arrays comprising electrodes for electrophysiological recording and stimulation, biosensors, and 
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microfluidics. On the basis of a common fabrication process, three basic microprobe designs have 
been developed. The designs enable different assembly and integration strategies resulting in 
microprobe comb and array assemblies, floating microprobe arrays, and complete drug delivery 
systems. Beyond the technical description of the devices, application examples are presented.  
All animal related procedures complied with the legal and ethical requirements and local institutional 
guidelines at the University of Cambridge, United Kingdom, and the Katholieke Universiteit Leuven, 
Belgium. 
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Material and Methods 
Fluidic silicon microprobe concept 
The modular platform approach pursued by NeuroProbes is based on the insertion of individual 2D 
probe combs into a common platform to obtain a complete 3D array as described in [31-34]. Beyond 
this, different probe designs offering distinct interfaces for stand-alone assemblies are desirable for 
versatile applications. In order to address both aspects, a two-wafer bonding process was developed 
which is compatible with the processes and materials of the modular platform approach pursued by 
NeuroProbes. In addition, the process offers maximum flexibility in the geometrical probe design as 
well as the fluidic layout. The applied materials are silicon (Si) as the probe material and silicon oxide 
(SiO2) as well as nitride (SiN) used as passivation layers. As exemplary illustrated in Figure 1, three 
basic microprobe designs with various fluidic features have been implemented [8,20] enabling 
different assembly strategies as described later. Thereby both, in-plane and out-of-plane fluidic 
supplies as well as outlet ports have been developed. Probe design A (Figure 1A) comprises two 
slender 8-mm-long shafts with a pitch of 1.5 mm attached to a common base. Each shaft has a cross-
sectional area of 250×250 μm², includes a microfluidic channel, and features four planar electrodes 
with a diameter of 20 μm and a pitch of 500 μm located up- and downstream of the liquid outlet ports. 
The 4×4 mm² common base with a thickness of 400 µm is used for handling as well as system 
integration and provides access to the electrodes and microfluidic channels. For liquid supply, tubing 
can be directly sleeved over the protruding rectangular connectors having outer dimensions of 
400×400 μm², lengths of 1 mm, and in-plane inlet ports. Starting at the inlet port, the rectangular 
microfluidic channel narrows from 200×50 μm² to 50×50 μm² in the shaft and is terminated by a 
circular out-of-plane outlet port with a diameter of 25 μm. The electrodes can be accessed by 
150×300 μm² bond pads on the probe base. 
Probe design B (Figure 1B) differs from probe design A by a larger common base of 6×4 mm² with 
circular out-of-plane inlet ports located at the bottom surface. The out-of-plane inlet ports with a 
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diameter of 300 µm allow reversible fluidic interfacing to the platform by using O-rings. 
Alternatively, they enable bonding of a fluidic packaging onto the flat surface by using adhesive. 
Probe design C (Figure 1C) represents a probe comb for the assembly into the NeuroProbes floating 
slim-base platform [31-33]. For this purpose, the shafts are attached to a common base featuring four 
protruding segments with widths of 390 µm and lengths of 220/420 µm enabling to mechanically 
secure the comb in the platform. The common base of these probe combs has a thickness of 300 μm 
and is 2020×325 μm² in size. Among the 8-mm-long shafts, the two outer shafts comprise fluidic 
microchannels and have a rectangular cross-sectional area of 250×200 μm², whereas the shafts in the 
middle reserved exclusively for electrodes are narrowed down to 150×200 μm². Hence, compared to 
probe designs A and B, the shafts of design C are thinner. Liquid supply to the fluidic shafts is 
achieved by in-plane inlet ports in the two outer segments. In view of design flexibility, the comb base 
can be used for integrating fluidic channels to the inner shafts as well. Similar to design A, the cross 
sections of the microchannels narrow from 200×50 μm² at the inlet port to 50×50 μm² in the shafts. 
The channels are terminated by two in-plane outlet ports of 50×50 μm² implemented at the shaft 
flanks, as illustrated with the inset in Figure 1C. In addition, each shaft features four circular 
electrodes with a diameter of 50 µm and a pitch of 400 µm as well as one triangular tip electrode. All 
electrodes can be accessed by contact pads on the protruding segments as detailed elsewhere [31].  
Additionally, various sub-variants have been realized for each of these designs. For instance, probe 
variants with up to two individual microchannels per shaft and shaft thicknesses as thin as 150 µm are 
further described in [8,20]. 
Fabrication process 
The fluidic silicon microprobes are fabricated in a two-wafer silicon direct bonding process applying 
standard 4-inch silicon (100) wafers, deep reactive ion etching (DRIE), wafer grinding, and thin film 
processing, as described in detail in [8] for designs A and B and in [20] for design C. Dependent on 
the specific design and the intended probe thickness, the applied processing steps and wafer 
thicknesses vary slightly. 
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In the following, the fabrication steps are illustrated in case of probe design B using 300-µm-thick 
wafers as substrate material. The general fabrication steps are summarized in Figure 2. A two-stage 
DRIE process is first applied to define the fluidic channels as well as the outer shape of the probes in a 
first silicon wafer (Figure 2A,B), i.e. the channel wafer. Thereafter, the fluidic channels are covered by 
a second wafer using silicon direct bonding. This second cover wafer is then reduced in thickness from 
300 to 100 µm by wafer grinding (Figure 2C). Subsequently, both sides of the wafer compound are 
covered with silicon oxide and nitride followed by deposition and patterning of a 200/300-nm-thin 
gold/platinum (Au/Pt) stack to form electrodes as well as interconnecting leads and contact pads. The 
subsequent deposition and patterning of additional silicon oxide and nitride layers protects the tracks 
to the electrodes (Figure 2D). Finally, the probe geometry is further defined by DRIE from both wafer 
stack sides. Thereby, the rear etch realizes the out-of-plane inlet ports and additionally thins down the 
probe shafts to a thickness of 250 µm (Figure 2E), while the front etch implements the out-of-plane 
outlet ports (Figure 2F). 
This two-wafer bonding technology offers maximum flexibility in the design of the probe geometry as 
well as the microfluidic features. 
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Results 
General microprobe characteristics 
The general properties of the fabricated microprobes were characterized as described in detail in 
[8,20,35]. This includes measurements of the insertion forces, fluidic characteristics, and electrode 
impedances. In case of shaft cross sections of 250×250 μm², average insertion forces of 120 ± 13 mN 
at an insertion speed of 100 mm min−1 were determined in an agarose gel/polyethylene foil model 
representing the cortex and pia mater [8]. With respect to the infusion of water-based liquids, all 
microprobe designs require modest infusion pressures to achieve infusion rates on the order of 0.5-
3 µL/min. For instance, probe design A requires an infusion pressure of 1 kPa to achieve an infusion 
rate of 1.5 μL min−1 at a temperature of 26 °C [8]. Requiring electrical connection, the electrical 
impedances of the recording electrodes were determined after system assembly of the microprobes as 
detailed in the subsequent section. 
Microprobe comb assembly 
In order to apply the microprobes to in vivo experiments, a system assembly enabling connection of 
the microprobes to macroscale mechanical, fluidic, and electronic laboratory equipment is required. 
Considering this, the basic assembly shown in Figure 3 offering easy handling and robustness during 
operation was developed as described in [36]. In detail, the assembly provides three interfaces: (1) A 
robust polymer packaging which allows to conveniently mechanically clamp the system assembly 
during insertion, e.g. in a stereotactic frame. (2) Flexible inert tubing for fluidic connection which is 
easily adapted to laboratory equipment using commercially available fluidic connectors. (3) A 
commercial micro connector which offers pluggable electrical connections to the electrodes on the 
probe shafts. 
During the device assembly, the silicon microprobe comb (design A, cf. Figure 1A) is first bonded to 
the robust polyetheretherketone (PEEK) packaging by epoxy adhesive (EPO-TEK
®
 353ND-4, Polytec 
PT GmbH, Waldbronn, Germany). The protruding fluidic connectors at the platform of the microprobe 
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have a cross-sectional area of 400×400 μm². If fluidic tubing is directly sleeved over the connectors, a 
tubing inner diameter (ID) of 509 μm (based on equivalent circumferences) is required. This increases 
the dead volume of the system substantially. Therefore, medical grade heat-shrinkable tubing 
(Raychem MT2000, Tyco Electronics, Schaffhausen, Switzerland) is applied as an adaptor and allows 
to attach standard 50-cm-long polytetrafluoroethylene (PTFE) tubing having an ID of 300 μm and an 
outer diameter (OD) of 600 μm. After attachment, any remaining gaps resulting from the rectangular 
cross section of the connector are sealed with adhesive (EPO-TEK
®
 353ND-T, Polytec PT GmbH, 
Waldbronn, Germany). 
The electrical interface is realized by an electrical micro connector (CLM series, Samtec, Germering, 
Germany) attached to a custom-made flexible printed circuit board (FPCB, ANDUS Electronic, 
Berlin, Germany) by reflow soldering. The assembled FPCB is bonded to the microprobe platform as 
well as to the PEEK packaging by using adhesive (EPO-TEK
®
 353ND-T). Electrical connection 
between the FPCB and the bond pads on the microprobe platform is realized by wire bonding followed 
by protection with a glob top (EPO-TEK
®
 353ND-T). After assembly, the average impedance of the 
electrodes was measured to be 2.8 ± 1.3 MΩ at 1 kHz using the experimental setup described in [8]. 
However, if required, Pt-grey can be electrochemically deposited on the electrodes which reduces the 
average impedance to 65 ± 20 kΩ. 
Successful operation of the assembly was verified by acute in vivo experiments with anesthetized rats 
[36]. For this purpose, the assembly was mounted to the holder of a stereotactic frame and connected 
to a conventional syringe pump. During insertion, the microprobe shafts easily penetrated the adult rat 
dura and no broken shafts were observed. After insertion, microinfusions could be successfully 
administered to a variety of brain areas. The electrode configuration of the microprobe shafts is 
sketched in Figure 4A. In parallel, a stainless steel skull screw placed nearby with an impedance of 
350 Ω was applied as a differential electrode. Using this configuration, recordings of spontaneous 
single neuron spikes in the cerebellum could be obtained from different electrodes as shown in Figure 
4B. The impact of drug delivery on the electrophysiological activity was also assessed in a separate 
experiment by measuring the effects of a small infusion of lidocaine (a sodium channel blocker) on 
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evoked local field potentials (LFPs) in the sensory cortex [37]. Figure 4C shows the lidocaine-induced 
suppression of forelimb-evoked LFPs in the rat primary somatosensory cortex. The evoked potentials 
show an early positive deflection (onset ~10 ms) with a longer latency negative deflection (onset 
~20 ms), consistent with previous studies [38]. Following lidocaine infusion, the peak-to-trough 
amplitude of the forelimb potential was reduced to 27% of its original amplitude (260 µV reduced to 
70 µV). After 20 minutes of recovery time, the forelimb-evoked potential recovered to 65 % (170 µV) 
of its peak-to-trough amplitude as the effects of the infused lidocaine declined. 
Microprobe array assembly 
A microprobe array assembly can be considered as an intermediate step between a microprobe comb 
assembly (2D) and a fully floating microprobe array (3D). Being not as miniaturized as a floating 
array, such an assembly can serve as an acute and semi-chronic research tool providing neuroscientists 
with the possibility for simultaneous neural recording combined with drug delivery. An image of the 
developed microprobe array assembly primarily designed for use with larger subjects such as non-
human primates is shown in Figure 5 [39]. The assembly consists of a small PEEK spacer onto which 
two microprobe combs (design A, cf. Figure 1A) are bonded by using adhesive (EPO-TEK
®
 353 ND-
4) resulting in a 3D microprobe array. Thereby, the spacer forms not only the basis of the array, but 
enables also the reversible docking of a neuronavigation positioning tool in form of a special stainless 
steel rod. The fluidic connections to the microprobes are realized by two-component tubing: a piece of 
rigid polyamide (PA) tubing is sleeved over the protruding connectors of the microprobe into which 
flexible polyethylene (PE) tubing is inserted and secured with EPO-TEK
®
 353ND-T adhesive. The 
tubing is terminated by the commercially available injection port (SIP22/4, Instech Laboratories Inc., 
Plymouth Meeting, PA, USA) shown in Figure 7C which is compatible with magnetic resonance 
imaging (MRI). In order to access the total of 16 recording electrodes, two highly flexible polyimide 
(PI) ribbon cables are used [40]. The cables are connected to the bond pads of the microprobes as well 
as a small PCB with an attached connector (Nanoseries, Omnetics Connector Corporation, 
Minneapolis, USA) by applying the Microflex technology described in detail elsewhere [41,42]. After 
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cable assembly, the electrical connections are protected by silicone (MED-2000, NuSil Technology, 
Carpinteria, CA, USA). 
The microprobe array assembly was applied to semi-chronic behavioral experiments in non-human 
primates [39]. Specifically, temporary inactivation of the anterior intraparietal (AIP) area by 
stimulating the chief inhibitory neurotransmitter gamma-aminobutyric acid (GABA) with the agonist 
muscimol in conjunction with grasping experiments was addressed.  
In order to investigate the spread of liquid by MRI, a mixture of muscimol and the MRI-contrast agent 
Dotarem
®
 (Guerbet, Villepinte, France) was used. After priming, a device was implanted inside of a 
custom-built MRI-compatible PEEK recording chamber typically used for such experiments [43,44]. 
Following craniotomy, the cylinder was anchored on the skull by dental cement enabling permanent 
access to the exposed dura mater. During implantation, the microprobes were oriented towards the 
target region (AIP area) by using the neuronavigation system Brainsight™ (Rogue Research Inc., 
Montreal, Canada) and inserted directly through the dura mater. In some cases, the dura was slightly 
thinned before insertion. All microprobe shafts survived the insertion procedure.  After a recovery 
period, repeated reversible inactivations of the AIP were performed by injection volumes varying 
between 0.5 and 4 µL. Anatomical MRI scans at a resolution of 0.6 mm isotropic after injection are 
shown in Figure 6. Localized injections of 1-2 µL into the AIP caused a deficit in grasping with the 
contralateral hand which correlated well with the liquid spread shown in Figure 6A and is consistent 
with previous findings [45]. The deficit disappeared 24 hours after the injection which is typical for 
this kind of inactivation experiments. In case of larger injection volumes of 4 µL, the muscimol 
solution spread to the medial bank of the intraparietal sulcus (IPS) as shown in Figure 6B. The 
resulting inactivation of the medial bank caused an additional deficit in reaching, i.e. correct direction 
of the arm to obtain a food reward. The microprobe array assembly remained implanted over a time 
period of 28 days. During this time, no clogging of the fluidic channels was observed. However, in 
general the array assembly is not intended for longer implantation times. Due to the size of the array 
backbone, the probes can shift inside the recording cylinder, possibly causing lesions in the brain. 
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Floating microprobe array 
In case of a chronically implanted multifunctional 3D microprobe array, additional aspects need to be 
considered [20]: During implantation, the array has to be placed in the small space between skull and 
brain. However, blood pulsation and head movements cause permanent relative motions of the brain 
with respect to the surrounding skull. If the array is rigidly connected to the skull, the stiff and fixed 
array shafts can interfere with the brain motions, possibly causing tissue damage. Therefore, starting at 
a certain brain size, the array must be mechanically decoupled from the skull and be able to “float” on 
the brain surface. Considering these boundary conditions, the backbone of the array (i.e. the platform) 
should be as thin as possible. In addition, the connecting electrical and fluidic cables are required to be 
highly flexible in order to prevent any mechanical interference with the floating operation. 
To address these demands, the developed floating microprobe array for neural drug delivery shown in 
Figure 7D relies on a slim-base platform in conjunction with an elastic microfluidic cable for liquid 
supply. Microprobe combs, platform, and microfluidic multilumen cable are first fabricated as 
individual components followed by assembly as described in detail in [20]. 
Fabrication of the platform is based on a two-step DRIE process combined with wafer grinding of 
500-μm-thick 8-inch silicon (100) wafers. The resulting 300-µm-thin platform has a footprint of 
4000×4000 μm² and offers 4×4 bays enabling the insertion of up to four individual probe combs. 
Liquid supply to the inserted probes is realized from the platform rear. For this purpose, the bays in the 
corners are implemented as through-connections. 
The microfluidic cable is fabricated by replica molding and oxygen plasma bonding of two silicone 
films (MED-6015, NuSil Technology, Carpinteria, CA, USA). The resulting highly elastic 
microfluidic cable has a final thickness of only 250 μm and contains four independent microfluidic 
channels each having a cross section of 300×50 µm². The distal end of the microfluidic cable is 
terminated by a PEEK adaptor with four injection ports (SIP22/4) for fluidic supply. To infuse liquids, 
the injection port exemplary shown in Figure 7C is connected with a septum needle. 
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During assembly, the silicone cable enabling liquid delivery to the four bays with through-connections 
is first attached to the platform rear side by oxygen plasma bonding. Then, the protruding segments of 
the individual fluidic probe combs (design C, cf. Figure 1C) are inserted into the platform and secured 
with adhesive (EPO-TEK
®
 301, Polytec PT GmbH, Waldbronn, Germany) as illustrated in Figure 7A. 
A scanning electron micrograph of the protruding segments is shown in Figure 7B. 
In a laboratory setup, liquid delivery through all four fluidic shafts could be successfully demonstrated 
and characterized [20]. 
Chronic drug delivery system NeuroMedicator 
In neuroscience, microinfusions of drugs directly into the central nervous system of awake animals are 
widely used to investigate brain functions related to behavior. However, whereas small, skull-mounted 
transmitters (headstages) for wireless electrophysiological recordings are already commercially 
available, drug delivery relies mostly on tethered liquid infusion systems with a stationary syringe 
pump possibly interfering with behavior. This shortfall is addressed by the NeuroMedicator [27,28] 
combining a fluidic microprobe comb (design B, cf. Figure 1B) with a micropumping system. The 
NeuroMedicator illustrated in Figure 8A features 2×8 discrete liquid reservoirs interconnected in a 
pearl-chain-like manner which can be infused on demand. With outer dimensions of 20×17.5×5 mm³, 
the device is small and lightweight enough to be placed directly on the skull of a rat. A detailed 
description of the device is provided elsewhere [28]. 
The operational concept of the NeuroMedicator is illustrated in Figure 8B. The drug liquid is stored in 
the reservoir plate, i.e. a plate with interconnected reservoirs sealed on one side with an elastic film. 
Prior to implantation, the liquid is loaded into the reservoirs through the microprobe by applying 
vacuum. After implantation and electrical connection, discrete 0.25 μL infusions can be sequentially 
released. For this purpose, short heating pulses each requiring 3.375 Ws of heating energy are applied 
to the composite underneath an individual reservoir. The resulting irreversible expansion deforms the 
elastic film into the reservoir, displaces the liquid, and releases it through the microprobe directly to 
the neural tissue. 
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The required volumetric expansion is realized by thermally expandable Expancel
®
 microspheres 
(Expancel, Sundsvall, Sweden) embedded into an elastic polydimethylsiloxane (PDMS) matrix [46]. 
Expancel
®
 microspheres are polymeric shells with a diameter of about 10 μm which contain a liquid 
hydrocarbon. At room temperature, the hydrocarbon is volatile and needs to be stored above its vapor 
pressure. Heating of the microspheres softens the polymeric shell and increases further the vapor 
pressure. Above a critical temperature of about 80° C, the soft shell cannot withstand the internal 
pressure anymore and starts to expand. Thereby, the relaxing vapor pressure propels a volumetric 
expansion by a factor of up to 60 [47]. When temperature is decreased again, the expanded polymeric 
shell solidifies and prevents shrinkage. 
The reservoir plate with the microprobe comb, the microheater array with the expandable material on 
top, and the device housing are first fabricated and pre-assembled as individual components followed 
by assembly of the complete NeuroMedicator. 
In case of the reservoir plate, the liquid reservoirs are milled as spherical caps into a rigid cyclo-olefin 
polymer (COP) plate (Zeonor 1420R, Zeon Europe GmbH, Düsseldorf, Germany) and sealed with a 
laser-welded thermoplastic elastomer (TPE) film (HTF 9467/44, KRAIBURG TPE GmbH & Co. KG, 
Waldkraiburg, Germany). After this, the common base of a microprobe comb (design B, cf. Figure 
1B) is adhesively bonded to the front side (EPO-TEK
®
 353ND, Polytec PT GmbH, Waldbronn, 
Germany). Finally, the barrier properties of the TPE film are increased by a sputtered layer of 
aluminum (Al).  
The expandable material is a composite of Expancel 820 DU 40 (Expancel, Sundsvall, Sweden) and 
PDMS RTV615 (Momentive Performance Materials Inc., Albany, NY, USA). To be used for 
actuation, a 500-μm-thick layer is deposited by spin coating and cured on top of a PCB-based 
microheater array. The microheater array specifically developed for this application features 
micromachined titanium (Ti) heaters on one side and a reflow soldered electrical micro connector 
(CLM series, Samtec, Germering, Germany) on the other side. 
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During assembly, the microheater array with the expandable material and the reservoir plate with the 
attached microprobe comb are subsequently mounted into a robust poly(methyl methacrylate) 
(PMMA) housing and secured with adhesive (EPO-TEK
®
 353ND-T). A photograph of an assembled 
NeuroMedicator is shown in Figure 8C. 
The NeuroMedicator was successfully evaluated as a tool for pharmacological manipulation of 
behavior in the 5-choice serial reaction time task (5-CSRTT) [28], a behavioral test of visual attention 
and impulsivity. During the 5-CSRTT, a rat is trained to respond to one of five stimulation lights and a 
correct answer is rewarded with a food pellet. A schematic drawing of the 5-CSRTT apparatus is 
shown in Figure 9 and described in detail elsewhere [48,49]. 
For evaluation, a device filled with the N-methyl-D-aspartate (NMDA) receptor antagonist 3-((R)-2-
Carboxypiperazin-4-yl)-propyl-1-phosphonic acid, (R)-CPP, was implanted into a rat trained to 
perform the 5-CSRTT. (R)-CPP infusions targeted to the ventromedial prefrontal cortex (or 
infralimbic cortex) are known to increase the likelihood of rats to respond impulsively [50,51], i.e. to 
respond before the occurrence of a light stimulus in expectation of a food reward. 
The frequency of impulsive responses was characterized before and after device implantation as 
shown in Figure 9. Thereby, the stable base line at the first three days after implantation suggests that 
passive drug leakage from the probe outlets is negligible. On the eighth day, a bilateral infusion of 
0.25 µL (R)-CPP targeted to the infralimbic cortices was performed. Immediately after infusion, 
impulsive responding was approximately three-fold higher, but recovered to control levels on the 
subsequent days.  
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Discussion 
Different approaches for intracortical drug delivery by silicon fluidic microprobes developed within 
the NeuroProbes project have been summarized. Although micromachined probes represent certainly 
the key components for such approaches, the assembly of microprobes to complete systems offering 
distinct interfaces is required to enable practical applicability. Whereas chronic electrophysiological 
recordings can be performed today with pluggable wireless headstages, drug delivery typically 
requires tubing and tethered arrangements which limits its application in combination with chronic 
electrophysiology. Considering especially future therapeutic applications of intracortical probes, 
remote drug delivery is of high priority. However, as discussed above, the development of fluidic 
interfaces presents a formidable challenge. The two-wafer bonding process developed in NeuroProbes 
offers not only a maximum flexibility in the microprobe geometry, but considers also possibilities for 
flexible fluidic interfacing. For instance, fluidic inlet and outlet ports in virtually all spatial directions 
can be implemented. This flexibility was exploited to realize different assemblies. 
The microprobe comb assembly can be considered to be the basic assembly concept enabling easy 
access to the general functionalities of the microprobe, but requires permanently attached tubing. This 
limits its application mostly to acute experiments. On the other hand, the microprobe array assembly 
offers an increased flexibility as the injection ports allow the experimenter to reversibly connect and 
disconnect the liquid supply. However, one has to consider that insertion and backtracking of the 
septum needle can already cause a liquid displacement of about 1 μL resulting in infusion and suction, 
respectively. In addition, the presently used injection port confines a dead volume of around 8 µL. The 
array assembly can be used within a standard recording chamber, but chronically implanted assemblies 
require a slimmer backbone. This issue was addressed by the floating microprobe array approach 
having a total backbone thickness of only 550 μm. Similar to a highly flexible electrical ribbon cable, 
an elastic microfluidic multilumen cable is applied to supply the array with liquid, thereby maintaining 
floating operation. Unfortunately, high mechanical elasticity and barrier properties are typically 
contradictory requirements. Therefore, diffusive species transport through the walls of the microfluidic 
cable during implantation needs to be considered. Regarding a reversibly connectable liquid supply, 
 19 
the same considerations as for the microprobe array assembly apply. With respect to a multifunctional 
array, electrodes on the microprobe combs as well as proven electrical interconnect technologies to the 
platform [31,32] are available. This allows not only to assemble a floating array combining drug 
delivery with electrophysiology, but also to integrate probe combs with additional functions, e.g. 
combs with CMOS-electronics for electronic depth control [52,53] or mechanical stress mapping [54].  
In general, localized drug delivery into a specific brain region is challenging. In case of pressure-
driven brain infusions, liquid backflows along the applied catheters and cannulas are commonly 
observed depending on the infusion parameters [55,56]. Similarly, backflows along the shafts of the 
developed microprobes can occur [35]. 
If liquid is stored in a remote drug delivery device for the entire experiment, no pluggable fluidic 
interfaces are required and an autonomous drug-on-demand system results. The NeuroMedicator was 
developed as an add-on device to be used in conjunction with a headstage in small animal research. 
After filling and electrical connection, individual drug doses of 0.25 µL can be infused in both 
hemispheres of the brain. Future development directions could target wirelessly controlled drug 
delivery combined with electrophysiology. For this purpose, the microprobe comb of the 
NeuroMedicator features recording electrodes. Thereby, a modified recording and stimulation 
headstage could be used for both wireless control of drug delivery as well as electrophysiology. 
On the basis of the presented work, further multifunctional probes and assemblies have been 
developed. For instance, biosensors were integrated onto probe design B and successfully 
characterized [21]. Thereby, a reversible packaging taking advantage of the out-of-plane inlet ports 
enables fluidic as well as electrical contact and reduces assembly time of the liquid-stored probes to 
less than two minutes. In addition, alternative fabrication sequences have been derived from the 
presented core processes. In this respect, a fabrication process replacing the Si cover of probe design A 
with a 10-μm-thick bonded PI film was developed. By applying this process, microfluidic neural 
probes with in-channel electrodes were successfully fabricated and characterized [57]. 
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Figure legends 
Figure 1  Fluidic silicon microprobe designs: Design A and B offer a common probe base with in- and 
out-of-plane inlet ports, respectively, as well as out-of-plane outlet ports. Design C features in-plane 
outlet ports while the common base offers protruding segments with integrated in-plane inlet ports for 
assembly into a floating platform. 
Figure 2  General fabrication steps of the silicon microprobes: (A),(B) two-stage DRIE process to 
implement the channel structure and probe shape, (C) direct wafer-to-wafer bonding and grinding, (D) 
deposition and patterning of electrodes, (E) rear and (F) front side oxide patterning followed by DRIE 
for probe patterning. 
Figure 3  Microprobe comb assembly with attached PTFE-tubing and micro connector serving as 
fluidic and electrical interfaces, respectively, in comparison to a one Euro-Cent-coin. 
Figure 4  Results of acute experiments: (A) Electrode configuration of the microprobe shafts; (B) 
spontaneous single neuron spikes in cerebellum (raw data and superimposed spike waveforms); (C) 
lidocaine-induced inactivation of forelimb-evoked LFPs in the rat primary somatosensory cortex after 
delivery of 0.4 μL of a 5% lidocaine solution. The data shown are averages of five stimuli. The LFPs 
were recorded with electrode no. 6 next to the liquid outlet port. 
Figure 5  Microprobe array assembly with 2×2 probe shafts offering an electrical micro connector, 
dockings for injection ports, and a guidance for a positioning tool. 
Figure 6  MRI scans after injection of (A) 2 µL of a Muscimol/Dotarem
®
 mixture in a non-human 
primate’s AIP and (B) additional liquid spread to the medial bank of the IPS after injection of 4 µL. 
Figure 7  Floating microprobe array: (A) illustration of the comb assembly into the floating platform; 
(B) scanning electron micrograph of a probe comb with electrodes; (C) injection port with septum 
needle; (D) image of an assembled array with inserted combs (without electrodes). 
Figure 8  Drug delivery system NeuroMedicator: (A) Illustration of the device concept; (B) principle 
of operation based on (1) individual liquid reservoirs sealed on one side with an elastic film, (2) filling 
with liquid in vacuum, and (3),(4) localized heating of the expandable material displacing discrete 
liquid amounts; (C) photograph of an assembled NeuroMedicator. 
Figure 9 Percentage of impulsive responses during the 5-CSRTT before and after infusion of (R)-CPP 
into the rat mPFC. The NeuroMedicator was implanted on the fourth day. 
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